Study of a new drug for heart disease and inflammation
Part of Heart & circulation clinical trials.
This study tests a new medicine called YMI024 for people with stable coronary artery disease (blockages in heart arteries) and higher than normal levels of inflammation. The drug aims to reduce inflammation and may lower the risk of future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have stable coronary artery disease, such as a past heart attack, a stent or bypass surgery, or a scan showing significant blockage.
- Your blood test shows elevated C-reactive protein (hsCRP) at two separate screenings, at least a week apart.
- You have not had a major heart event, surgery, or stroke within the past few weeks or months.
- You do not have active or chronic infections, autoimmune diseases, or severe kidney or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new drug called YN001 can help people with coronary atherosclerosis (narrowing of heart blood vessels). The trial aims to see if it can improve outcomes in people who have early-stage blockages in their heart arteries.
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
This study compares two types of coronary artery disease: one linked to inflammation (IR-CAD) and the standard type (AS-CAD). If you have had a heart procedure and were recently hospitalized for worsening chest pain, this study may help doctors understand your condition better.
This trial tests whether adding a special scan to look at the fatty plaque in your arteries can help your doctor decide if you need stronger heart medication to prevent future heart attacks or strokes. If you have moderate blockages and signs of inflammation, you may be able to join.
This trial tests a new stent (a small mesh tube placed in your heart artery to keep it open) called MiStent II. The stent slowly releases a medicine to help prevent the artery from narrowing again. If you have coronary artery disease and need a stent, this study may help improve your treatment.
This study looks at real-world outcomes for people with narrowed heart arteries (coronary artery disease). It may include those treated with stents (PCI) or medicines. Doctors will use a special computer tool to measure the severity of blockages and track health over time.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.